HROW Q1 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$35M+32.5% YoY

Gross Profit

$24M69.5% margin

Operating Income

-$7M-20.0% margin

Net Income

-$14M-39.2% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$296M

Total Liabilities

$235M

Stockholders' Equity

$61M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$26M	+32.5%
Gross Profit	$24M	$18M	+34.8%
Operating Income	-$7M	$1M	-672.6%
Net Income	-$14M	-$7M	-104.2%

Revenue Segments

Other Revenues

$79,000100%